BMY vs INCY
Bristol Myers Squibb vs INCY — AI-powered side-by-side comparison
| Metric | BMY | INCY |
|---|---|---|
| AI Score | 55 | 66 |
| Price | $60.77 | $115.78 |
| P/E Ratio | 17.12× | 16.08× |
| ROE | 0.4% | 0.2% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.7% | 0.9% |
| Debt / Equity | 2.22× | 0.01× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 65.0 | 61.7 |
| Beta | 0.235 | 0.758 |
| Expected Upside | +0.2% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMY Full Analysis
INCY Full Analysis